Apyx medical reports q2 loss per share $0.14

Oration reports second quarter 2020 financial results.q2 loss per share $0.14.q2 revenue fell 35 percent to $4.3 million.q2 revenue estimate $2 million -- refinitiv ibes data.q2 earnings per share estimate $-0.21 -- refinitiv ibes data.as of june 30, 2020, had cash and equivalents of $46.2 million, compared to $58.8 million as of december 31, 2019.will not be providing full year 2020 financial guidance at this time.apyx medical - plan to provide updated expectations at the time of q3 results assuming more normalized business environment prevails.
APYX Ratings Summary
APYX Quant Ranking